ASHLEY SAUNDERS: Open Payments
NPI 1003680117 · PROVO, UT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$615 in 34 payments from 12 companies in 2025. Trend: 2023 $84 · 2024 $514 · 2025 $615
Food & beverage: $615
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 9 | $187 |
| Lilly USA, LLC | 9 | $129 |
| GlaxoSmithKline, LLC. | 5 | $83 |
| AstraZeneca Pharmaceuticals LP | 2 | $51 |
| Corcept Therapeutics | 2 | $45 |
| Neurocrine BioSciences, Inc. | 1 | $25 |
| SANOFI PASTEUR INC. | 1 | $20 |
| Edwards Lifesciences Corporation | 1 | $19 |
| Merck Sharp & Dohme LLC | 1 | $18 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $16 |
Products named: MOUNJARO, VRAYLAR, SHINGRIX, UBRELVY, AIRSUPRA, QULIPTA, Korlym, INGREZZA.
Industry payments across UT — which companies pay providers there.
